Professor of Methods of Clinical Trials, Julius Centrum, UMC Utrecht
Relevante publicaties
- Hilgers RD, Roes K, Stallard N; IDeAl, Asterix and InSPiRe project groups. Directions for new developments on statistical design and analysis of small population group trials. Orphanet Journal of Rare Diseases. 2016 Jun 14;11(1):78. doi: 10.1186/s13023-016-0464-5. PMID: 27301273.
- Baan, F.H. van der, Knol, M.J., Klungel, O.H., Egberts, A.C.G., Grobbee, D.E. & Roes, C.B. (2012). Potential of adaptive clinical trial designs in pharmacogenetic research. Pharmacogenomics, 13(5), 571-578.
- Wangge G, Klungel OH, Roes KCB, de Boer A, Hoes AW, Knol M.J. (2010) Room for Improvement in Conducting and Reporting Non-Inferiority Randomized Controlled Trials on Drugs: A Systematic Review. PLoS ONE 5(10): e13550. doi:10.1371/journal.pone.0013550.
- Wangge G., O H Klungel O.H., Roes, K.C.B., de Boer A., Hoes A.W., Knol M.J. (2010) Interpretation and Inference in Noninferiority Randomized Controlled Trials in Drug Research. Clinical Pharmacology & Therapeutics, 88 3, 420–423.
- Shein-Chung Chow, Jun Wang, Laszlo Endrenyi and Peter A. Lachenbruch (2013). Scientific considerations for assessing biosimilar products. Statist. Med. 2013, 32 370–381.
Volg ons via: